217 - Targeting IL-33 in the pathogenesis and treatment of bronchopulmonary dysplasia: potential for IL-33 antibody therapy.

Kenichi Suga, Tokushima University Hospital, Tokushima, Tokushima, Japan; Masashi Suzue, Tokushima University Hospital, Tokushima, Tokushima, Japan; Kanako Yoshizaki, Tokushima University Hospital, Tokushima, Tokushima, Japan; Ryuji Nakagawa, Tokushima Universiry, Tokushima, Tokushima, Japan; Maki Urushihara, Tokushima University Graduate School, Tokushima, Tokushima, Japan